Page last updated: 2024-10-28

hydroxychloroquine and Anemia, Aplastic

hydroxychloroquine has been researched along with Anemia, Aplastic in 4 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Anemia, Aplastic: A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Kuraitis, D1
Murina, A1
Kozak, N1
Friedman, J1
Schattner, A1
MCDUFFIE, FC1
Chute, JP1
Hoffmeister, K1
Cotelingam, J1
Davis, TA1
Frame, JN1
Jamieson, T1

Reviews

1 review available for hydroxychloroquine and Anemia, Aplastic

ArticleYear
Etanercept-associated transient bone marrow aplasia: a review of the literature and pathogenetic mechanisms.
    Drugs in R&D, 2014, Volume: 14, Issue:2

    Topics: Anemia, Aplastic; Anti-Bacterial Agents; Arthritis, Rheumatoid; Bone Marrow; Etanercept; Female; Fil

2014

Other Studies

3 other studies available for hydroxychloroquine and Anemia, Aplastic

ArticleYear
Facts, not Fear: Safety of Hydroxychloroquine.
    The American journal of the medical sciences, 2020, Volume: 360, Issue:2

    Topics: Acute Generalized Exanthematous Pustulosis; Agranulocytosis; Anemia, Aplastic; Antirheumatic Agents;

2020
BONE MARROW DEPRESSION AFTER DRUG THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
    Annals of the rheumatic diseases, 1965, Volume: 24

    Topics: Adolescent; Agranulocytosis; Anemia; Anemia, Aplastic; Anti-Bacterial Agents; Bone Marrow; Bone Marr

1965
Aplastic anemia as the sole presentation of systemic lupus erythematosus.
    American journal of hematology, 1996, Volume: 51, Issue:3

    Topics: Adult; Anemia, Aplastic; Bone Marrow; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Syste

1996